Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: Sweden Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20043
20052
20062
20073
20084
20094
20112
20123
20131
20154
20171
20181
20192
20211
20222
20233
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated4
Active, not recruiting3
Recruiting3
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
AstraZeneca4
Pfizer4
Karolinska University Hospital3
Novartis Pharmaceuticals3
Thomas Hatschek3
Bayer2
Lund University Hospital2
AbbVie1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms42
Neoplasms3
Biliary Tract Neoplasms2
Brain Neoplasms2
Neoplasm Metastasis2
Prostatic Neoplasms2
Bone Diseases1
Bone Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.